These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2623185

  • 1. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. III. Rapidly progressing glomerulonephritis and the use of converting enzyme inhibitors and non-steroidal anti-inflammatory drugs in idiopathic nephrotic syndrome].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989; 46(11):779-83. PubMed ID: 2623185
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C, Brosius FC, Palmieri J.
    Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
    [Abstract] [Full Text] [Related]

  • 3. [Treatment and prognosis of idiopathic membranous nephropathy in guidelines for nephrotic syndrome].
    Saito T.
    Nihon Jinzo Gakkai Shi; 2011 Jun; 53(5):708-12. PubMed ID: 21842605
    [No Abstract] [Full Text] [Related]

  • 4. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.
    Frigui M, Hmida MB, Jallouli M, Kechaou M, Frikha F, Bahloul Z.
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):320-2. PubMed ID: 20228521
    [Abstract] [Full Text] [Related]

  • 5. Idiopathic membranous nephropathy: new therapeutic trends.
    Rostoker G.
    Eur J Med; 1993 Feb; 2(2):106-16. PubMed ID: 8258013
    [No Abstract] [Full Text] [Related]

  • 6. [Therapy of primary chronic glomerulonephritis].
    Risler T, Braun N, Erley CM.
    Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993
    [Abstract] [Full Text] [Related]

  • 7. The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria.
    Asinobi AO, Gbadegesin RA, Adeyemo AA, Akang EE, Arowolo FA, Abiola OA, Osinusi K.
    West Afr J Med; 1999 Dec; 18(3):203-6. PubMed ID: 10593158
    [Abstract] [Full Text] [Related]

  • 8. [Late results and prognosis in glomerulonephritis. II. Prognosis in specific forms of glomerulopathies].
    Hruby Z.
    Przegl Lek; 1992 Dec; 49(1-2):28-30. PubMed ID: 1455001
    [No Abstract] [Full Text] [Related]

  • 9. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 10. Membranous nephropathy with severe tubulointerstitial and vascular changes in a patient with psoriatic arthritis treated with non-steroidal anti-inflammatory drugs.
    Grcevska L, Polenaković M, Ferluga D, Vizjak A, Stavrić G.
    Clin Nephrol; 1993 May; 39(5):250-3. PubMed ID: 8513600
    [Abstract] [Full Text] [Related]

  • 11. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 May; 46(10):744-9. PubMed ID: 2687950
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ, Wetzels JF.
    Ned Tijdschr Geneeskd; 1998 Dec 26; 142(52):2832-8. PubMed ID: 10065257
    [Abstract] [Full Text] [Related]

  • 13. Nephrotic syndrome after stem cell transplantation.
    Stevenson WS, Nankivell BJ, Hertzberg MS.
    Clin Transplant; 2005 Feb 26; 19(1):141-4. PubMed ID: 15659148
    [Abstract] [Full Text] [Related]

  • 14. [The immunosuppressive therapy of chronic (Bright's) nephritis].
    Krasnova TN, Shilov EM.
    Ter Arkh; 1993 Feb 26; 65(6):88-93. PubMed ID: 8378860
    [No Abstract] [Full Text] [Related]

  • 15. Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis.
    Imakiire T, Kikuchi Y, Yamada M, Kushiyama T, Higashi K, Hyodo N, Yamamoto K, Oda T, Suzuki S, Miura S.
    Hypertens Res; 2007 Jul 26; 30(7):635-42. PubMed ID: 17785932
    [Abstract] [Full Text] [Related]

  • 16. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 Jul 26; 46(12):816-21. PubMed ID: 2698488
    [No Abstract] [Full Text] [Related]

  • 17. [Lipoid nephrosis and idiopathic membranous glomerulonephritis in aduits. Our observations on its therapy (authros' transl].
    Knotková V, Stejkal J, Stejskalová A, Tomásek R.
    Cas Lek Cesk; 1977 Feb 04; 116(5):148-52. PubMed ID: 851970
    [No Abstract] [Full Text] [Related]

  • 18. [Clinico-pathological study on the nephrotic patients in the elderly].
    Oda K, Ito H, Ohashi T, Yamashita W, Harada R, Hashimoto S, Uemura S, Ueyama S, Osaki K, Nakashima A.
    Igaku Kenkyu; 1988 Dec 04; 58(6):411-6. PubMed ID: 3252680
    [No Abstract] [Full Text] [Related]

  • 19. [Nephrotic syndrome: don't forget to search for hypothyroidism].
    Trouillier S, Delèvaux I, Rancé N, André M, Voinchet H, Aumaître O.
    Rev Med Interne; 2008 Feb 04; 29(2):139-44. PubMed ID: 18191306
    [Abstract] [Full Text] [Related]

  • 20. [Rapidly progressing glomerulonephritis developing against a background of idiopathic nephrotic syndrome].
    Monova D, Belovezhdov N, Minova V, Doĭchinov D.
    Vutr Boles; 1988 Feb 04; 27(6):100-3. PubMed ID: 3247697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.